TheraRadar
Clinical-Stage Companies / Jina

Jina

Pre-Approval PRO BETA
🟡

Slowing Activity

No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 5/1/2025

6
Total Trials
4
Phase 3
2
Phase 2
2
Recruiting
76
Score

Pipeline by Phase

Phase 3
4
Phase 2
2
Phase 1

Therapeutic Focus

Metastatic Castration-resistant Prostate Cancer, MCRPC Triple Negative Breast Cancer Bipolar 1 Disorder Ulcerative Colitis (UC) Ulcerative Colitis, Active Moderate

Clinical Trials (6)

NCT03671044 Phase 3 RECRUITING

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

Started: 7/10/2018

NCT06608641 Phase 3 ACTIVE NOT RECRUITING

Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Started: 3/19/2024

NCT06867562 Phase 3 NOT YET RECRUITING

Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer

Started: 4/1/2025

NCT04315792 Phase 3 COMPLETED

Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Started: 8/3/2020

NCT06890832 Phase 2 NOT YET RECRUITING

A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer

Started: 5/1/2025

NCT06867042 Phase 2 NOT YET RECRUITING

Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment

Started: 4/1/2025

Drug Candidates

50 mg cabazitaxel 100 mg cabazitaxel 200 mg cabazitaxel Nanosomal Docetaxel Lipid Suspension (75 mg/m2) Nanosomal Docetaxel Lipid Suspension (100 mg/m2) Taxotere® (100 mg/m2) Endoxifen enteric-coated tablet (8 mg) Placebo Tablets Tacrolimus Lipid Suspension for enema Identical Tacrolimus-free Lipid Suspension for Enema
Activity Status: Slowing
Last Trial Started: 5/1/2025
Last Trial Ended: 8/25/2021
Trials (12 months): 0
Completed Trials: 1
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.